动脉样硬化中的调节T细胞:采用细胞疗法是否可能?
Alexey V Churov1, Yegor S Chegodaev2, Victoria A Khotina2
1Institute on Aging Research, Russian Gerontology Clinical Research Center, Pirogov Russian National Research Medical University, 129226 Moscow, Russia.
Life (Basel, Switzerland)
|September 28, 2023
概括
调节性T (Treg) 细胞对免疫平衡至关重要,对动脉样硬化有保护作用. 操纵这些细胞为治疗这种慢性炎症性血管疾病提供了一个有希望的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 病理学 病理学 病理学
背景情况:
- 动脉样硬化是一种慢性炎症性血管疾病,病因不明.
- 免疫细胞的透和脂质的积累驱动斑块的发展.
- CD4+调节性T (Treg) 细胞调节免疫反应并维持平衡.
研究的目的:
- 审查了解Treg细胞在动脉样硬化中的作用方面的最新进展.
- 讨论潜在的基于Treg细胞的治疗策略,用于动脉样硬化治疗.
主要方法:
- 对动脉样硬化中Treg细胞的实验数据和文献的审查.
- 分析FOXP3-表达的CD4+Treg细胞在动脉生成中的功能.
主要成果:
- 特雷格细胞通过抑制动脉样硬化斑块中的促炎性免疫反应来发挥保护作用.
- 尽管Tregs在斑块中起着至关重要的作用,但在斑块中发现了较少的Tregs.
- 实验数据支持基于Treg细胞的动脉样硬化疗法.
结论:
- 特雷格细胞是动脉样硬化中免疫平衡的关键调节者.
- 向Treg细胞是动脉样硬化治疗的一个有希望的翻译方法.
相关概念视频
01:26Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
01:24T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K